YK Bioventures Opportunities GP I, LLC's Form 4 filing
Cero Therapeutics Holdings, Inc. (CERO) · filed Dec 10, 2024
- Accession no.
- 0001415889-24-028899
- Filed
- Dec 10, 2024, 8:44 PM ET
- Trade date
- Dec 6-10, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $383.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| YK Bioventures Opportunities GP I, LLCCIK 0002042634 | 10% Owner |
| YK Bioventures Opportunities Fund I, L.P.CIK 0002042636 | 10% Owner |
| Kossar Mitchell WilliamCIK 0002042691 | 10% Owner |
| Yeung Gary KahingCIK 0002042700 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Common Stock | SSaleDisposed | −1,236,874 | $0.12 | −$148,424.88 | 21,383,909 | Indirect | |
| Dec 9, 2024 | Common Stock | SSaleDisposed | −850,543 | $0.11 | −$93,559.73 | 20,533,366 | Indirect | |
| Dec 10, 2024 | Common Stock | SSaleDisposed | −1,570,947 | $0.09 | −$141,385.23 | 18,962,419 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.